We’re thrilled to announce that Thu Anh Klimpke, Investor Relations of ZEISS Medical Technology Segment, is presenting a Deep Dive on the revolutionary Zeiss Smile procedure and is exploring the future of laser vision correction. Topics related to the company’s strategic business units, including the myopia trend, refractive laser surgery with ZEISS Smile, and more, are also presented.
During her presentation, Thu Anh provides valuable insights into the ZEISS Medical Technology Segment’s structure and offerings, which include two strategic business units: Ophthalmology and Microsurgery.
Within the Ophthalmology unit, ZEISS offers three key areas of focus: ophthalmic diagnostics, surgical ophthalmology, and refractive laser surgery.
Thu Anh delves into each area and closely examines the devices and consumables ZEISS offers.
One of the key topics that will be discussed during the presentation is the myopia trend. According to a study, one-third of the world’s population currently has myopia, with high myopia affecting one in 20 people. Thu Anh will explore the development of myopia in the coming decades, highlighting the increasing importance of laser vision correction for more and more people.
Moreover, Thu Anh will discuss ZEISS’s Smile technology, which stands for Small Incision Lenticule Extraction. She will explain how this technology differs from conventional laser vision correction procedures and how ZEISS offers a standalone solution.
Thu Anh also provides a detailed overview of the Visa Max 800, a femtosecond system offering outstanding incision precision, speed, and a gentle treatment approach.
Attendees of this presentation will gain valuable insights into the ZEISS Medical Technology Segment’s offerings and how the company is leading the way in laser vision correction technology.
Don’t miss out on this opportunity to learn from Thu Anh, Manager of Investor Relations for the ZEISS Medical Technology Segment.
Reviews for Carl Zeiss Meditec AG | Deep-Dive: ZEISS SMILE | Thu Anh Klimpke, IR